F.D.A. Experts Will Vote on a Cure for Sickle Cell Disease

F.D.A. Experts Will Vote on a Cure for Sickle Cell Disease

The New York Times - Business:

The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.

Gina Kolata
Author: Gina Kolata

This post first appeared in The New York Times - Business. Read the original article.